Gsk Plc ADR (NY: GSK )

38.56 -0.04 (-0.10%)

Official Closing Price Updated: 7:00 PM EDT, Jul 10, 2024 Add to My Watchlist

Price and Volume

Volume	2,376,638
Open	38.54
Bid (Size)	38.15 (1)
Ask (Size)	38.63 (2)
Prev. Close	38.60
Today's Range	38.44 - 38.65
52wk Range	33.67 - 45.92
Shares Outstanding	5,385,189,617
Dividend Yield	3.74%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time

Today 18:09 EDT

Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low.

Via Benzinga

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

July 09, 2024

A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher.

Via InvestorPlace

Performance

YTD	+2.80%	+2.80%
1 Month	-6.61%	-6.61%
3 Month	-5.23%	-5.23%
6 Month	-3.58%	-3.58%
1 Year	+13.01%	+13.01%

More News

Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows

July 08, 2024

Via Benzinga

United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win

July 05, 2024

Via Benzinga

Upcoming Stock Spinoffs: Should You Pounce or Pass?

July 04, 2024

Via InvestorPlace

CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts

July 03, 2024

Via InvestorPlace

CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK

July 03, 2024

Via InvestorPlace

GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B

July 03, 2024

Via Benzinga

3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024

July 03, 2024

Via The Motley Fool

Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims

July 02, 2024

Via Benzinga

CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK

June 27, 2024

Via Benzinga

Why Is Moderna Stock Trading Lower On Wednesday?

June 26, 2024

Via Benzinga

Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots

June 26, 2024

Via Investor's Business Daily

Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC

June 26, 2024

Via Benzinga

UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract

June 24, 2024

Via Benzinga

Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer

June 20, 2024

Via Benzinga

Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

June 20, 2024

Via FinancialNewsMedia

Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

June 20, 2024

From FN Media Group LLC

Via GlobeNewswire

Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs

June 18, 2024

Via Benzinga

7 A-Rated Biotech Stocks Worth Betting on in June

June 14, 2024

Via InvestorPlace

3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition

June 11, 2024

Via InvestorPlace

Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK

June 10, 2024

Via Investor's Business Daily

US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk

June 07, 2024

From GSK plc

Via Business Wire

The 3 Most Undervalued Pharma Stocks to Buy in June 2024

June 06, 2024

Via InvestorPlace

Large Cap BIopharmaceuticals Overview

June 03, 2024

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.